This phase II study is a four arm trial comparing amprenavir in combination with saquinavir, indinavir or nelfinavir in HIV infected subjects currently failing indinavir, fitonavir, saquinavir or nelfinavir treatment.
Showing the most recent 10 out of 381 publications